 | • レポートコード：MRC2-11QY01308 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はHIV薬のグローバル市場について調査・分析したレポートです。種類別（マルチクラス組合せ製品、ヌクレオシド逆転写酵素阻害剤、非ヌクレオシド逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、侵入阻害剤-CCR5共受容体拮抗薬、HIVインテグラーゼ鎖転移阻害剤）市場規模、用途別（病院薬局、小売薬局、オンライン薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別HIV薬の競争状況、市場シェア ・世界のHIV薬市場：種類別市場規模 2015年-2020年（マルチクラス組合せ製品、ヌクレオシド逆転写酵素阻害剤、非ヌクレオシド逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、侵入阻害剤-CCR5共受容体拮抗薬、HIVインテグラーゼ鎖転移阻害剤） ・世界のHIV薬市場：種類別市場規模予測 2021年-2026年（マルチクラス組合せ製品、ヌクレオシド逆転写酵素阻害剤、非ヌクレオシド逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、侵入阻害剤-CCR5共受容体拮抗薬、HIVインテグラーゼ鎖転移阻害剤） ・世界のHIV薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局、その他） ・世界のHIV薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局、その他） ・北米のHIV薬市場分析：米国、カナダ ・ヨーロッパのHIV薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのHIV薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のHIV薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのHIV薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb、Gilead Sciences、GlaxoSmithKline、Johnson & Johnson、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.
One of the primary factors catalyzing the growth of the global HIV drugs market is increase in the prevalence of HIV and its diagnosis. Apart from this, the market is also influenced by a rise in the number of government initiatives for spreading the awareness amongst people regarding causes, symptoms and treatments. Moreover, the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs, act as another factor that is contributing towards the demand for HIV drugs.
Market Analysis and Insights: Global HIV Drugs Market
The global HIV Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global HIV Drugs Scope and Market Size
HIV Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the HIV Drugs market is segmented into
Multi-Class Combination Products
Nucleoside Reverse Transcriptase Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Entry Inhibitors – CCR5 Co-Receptor Antagonist
HIV Integrase Strand Transfer Inhibitors
Segment by Application, the HIV Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Regional and Country-level Analysis
The HIV Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the HIV Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and HIV Drugs Market Share Analysis
HIV Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in HIV Drugs business, the date to enter into the HIV Drugs market, HIV Drugs product introduction, recent developments, etc.
The major vendors covered:
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
…
1 Study Coverage
1.1 HIV Drugs Product Introduction
1.2 Market Segments
1.3 Key HIV Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global HIV Drugs Market Size Growth Rate by Type
1.4.2 Multi-Class Combination Products
1.4.3 Nucleoside Reverse Transcriptase Inhibitors
1.4.4 Non-Nucleoside Reverse Transcriptase Inhibitors
1.4.5 Protease Inhibitors
1.4.6 Fusion Inhibitors
1.4.7 Entry Inhibitors – CCR5 Co-Receptor Antagonist
1.4.8 HIV Integrase Strand Transfer Inhibitors
1.5 Market by Application
1.5.1 Global HIV Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global HIV Drugs Market Size, Estimates and Forecasts
2.1.1 Global HIV Drugs Revenue 2015-2026
2.1.2 Global HIV Drugs Sales 2015-2026
2.2 Global HIV Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global HIV Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global HIV Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global HIV Drugs Competitor Landscape by Players
3.1 HIV Drugs Sales by Manufacturers
3.1.1 HIV Drugs Sales by Manufacturers (2015-2020)
3.1.2 HIV Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 HIV Drugs Revenue by Manufacturers
3.2.1 HIV Drugs Revenue by Manufacturers (2015-2020)
3.2.2 HIV Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global HIV Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by HIV Drugs Revenue in 2019
3.2.5 Global HIV Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 HIV Drugs Price by Manufacturers
3.4 HIV Drugs Manufacturing Base Distribution, Product Types
3.4.1 HIV Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers HIV Drugs Product Type
3.4.3 Date of International Manufacturers Enter into HIV Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global HIV Drugs Market Size by Type (2015-2020)
4.1.1 Global HIV Drugs Sales by Type (2015-2020)
4.1.2 Global HIV Drugs Revenue by Type (2015-2020)
4.1.3 HIV Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global HIV Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global HIV Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global HIV Drugs Revenue Forecast by Type (2021-2026)
4.2.3 HIV Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global HIV Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global HIV Drugs Market Size by Application (2015-2020)
5.1.1 Global HIV Drugs Sales by Application (2015-2020)
5.1.2 Global HIV Drugs Revenue by Application (2015-2020)
5.1.3 HIV Drugs Price by Application (2015-2020)
5.2 HIV Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global HIV Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global HIV Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global HIV Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America HIV Drugs by Country
6.1.1 North America HIV Drugs Sales by Country
6.1.2 North America HIV Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America HIV Drugs Market Facts & Figures by Type
6.3 North America HIV Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe HIV Drugs by Country
7.1.1 Europe HIV Drugs Sales by Country
7.1.2 Europe HIV Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe HIV Drugs Market Facts & Figures by Type
7.3 Europe HIV Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific HIV Drugs by Region
8.1.1 Asia Pacific HIV Drugs Sales by Region
8.1.2 Asia Pacific HIV Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific HIV Drugs Market Facts & Figures by Type
8.3 Asia Pacific HIV Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America HIV Drugs by Country
9.1.1 Latin America HIV Drugs Sales by Country
9.1.2 Latin America HIV Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America HIV Drugs Market Facts & Figures by Type
9.3 Central & South America HIV Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa HIV Drugs by Country
10.1.1 Middle East and Africa HIV Drugs Sales by Country
10.1.2 Middle East and Africa HIV Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa HIV Drugs Market Facts & Figures by Type
10.3 Middle East and Africa HIV Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb HIV Drugs Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Corporation Information
11.2.2 Gilead Sciences Description and Business Overview
11.2.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Gilead Sciences HIV Drugs Products Offered
11.2.5 Gilead Sciences Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline HIV Drugs Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson HIV Drugs Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck HIV Drugs Products Offered
11.5.5 Merck Related Developments
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Corporation Information
11.1.2 Bristol-Myers Squibb Description and Business Overview
11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol-Myers Squibb HIV Drugs Products Offered
11.1.5 Bristol-Myers Squibb Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 HIV Drugs Market Estimates and Projections by Region
12.1.1 Global HIV Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global HIV Drugs Revenue Forecast by Regions 2021-2026
12.2 North America HIV Drugs Market Size Forecast (2021-2026)
12.2.1 North America: HIV Drugs Sales Forecast (2021-2026)
12.2.2 North America: HIV Drugs Revenue Forecast (2021-2026)
12.2.3 North America: HIV Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe HIV Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: HIV Drugs Sales Forecast (2021-2026)
12.3.2 Europe: HIV Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: HIV Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific HIV Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: HIV Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: HIV Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: HIV Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America HIV Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: HIV Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: HIV Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: HIV Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa HIV Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: HIV Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: HIV Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: HIV Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key HIV Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 HIV Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. HIV Drugs Market Segments
Table 2. Ranking of Global Top HIV Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global HIV Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Multi-Class Combination Products
Table 5. Major Manufacturers of Nucleoside Reverse Transcriptase Inhibitors
Table 6. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 7. Major Manufacturers of Protease Inhibitors
Table 8. Major Manufacturers of Fusion Inhibitors
Table 9. Major Manufacturers of Entry Inhibitors - CCR5 Co-Receptor Antagonist
Table 10. Major Manufacturers of HIV Integrase Strand Transfer Inhibitors
Table 11. Global HIV Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global HIV Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global HIV Drugs Sales by Regions 2015-2020 (K MT)
Table 14. Global HIV Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global HIV Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global HIV Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global HIV Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global HIV Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global HIV Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Drugs as of 2019)
Table 20. HIV Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. HIV Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers HIV Drugs Price (2015-2020) (USD/MT)
Table 23. HIV Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers HIV Drugs Product Type
Table 25. Date of International Manufacturers Enter into HIV Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global HIV Drugs Sales by Type (2015-2020) (K MT)
Table 28. Global HIV Drugs Sales Share by Type (2015-2020)
Table 29. Global HIV Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global HIV Drugs Revenue Share by Type (2015-2020)
Table 31. HIV Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global HIV Drugs Sales by Application (2015-2020) (K MT)
Table 33. Global HIV Drugs Sales Share by Application (2015-2020)
Table 34. North America HIV Drugs Sales by Country (2015-2020) (K MT)
Table 35. North America HIV Drugs Sales Market Share by Country (2015-2020)
Table 36. North America HIV Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America HIV Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America HIV Drugs Sales by Type (2015-2020) (K MT)
Table 39. North America HIV Drugs Sales Market Share by Type (2015-2020)
Table 40. North America HIV Drugs Sales by Application (2015-2020) (K MT)
Table 41. North America HIV Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe HIV Drugs Sales by Country (2015-2020) (K MT)
Table 43. Europe HIV Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe HIV Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe HIV Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe HIV Drugs Sales by Type (2015-2020) (K MT)
Table 47. Europe HIV Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe HIV Drugs Sales by Application (2015-2020) (K MT)
Table 49. Europe HIV Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific HIV Drugs Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific HIV Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific HIV Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific HIV Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific HIV Drugs Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific HIV Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific HIV Drugs Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific HIV Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America HIV Drugs Sales by Country (2015-2020) (K MT)
Table 59. Latin America HIV Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa HIV Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America HIV Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America HIV Drugs Sales by Type (2015-2020) (K MT)
Table 63. Latin America HIV Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America HIV Drugs Sales by Application (2015-2020) (K MT)
Table 65. Latin America HIV Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa HIV Drugs Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa HIV Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa HIV Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa HIV Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa HIV Drugs Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa HIV Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa HIV Drugs Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa HIV Drugs Sales Market Share by Application (2015-2020)
Table 74. Bristol-Myers Squibb Corporation Information
Table 75. Bristol-Myers Squibb Description and Major Businesses
Table 76. Bristol-Myers Squibb HIV Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Bristol-Myers Squibb Product
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Gilead Sciences Corporation Information
Table 80. Gilead Sciences Description and Major Businesses
Table 81. Gilead Sciences HIV Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Gilead Sciences Product
Table 83. Gilead Sciences Recent Development
Table 84. GlaxoSmithKline Corporation Information
Table 85. GlaxoSmithKline Description and Major Businesses
Table 86. GlaxoSmithKline HIV Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Recent Development
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Description and Major Businesses
Table 91. Johnson & Johnson HIV Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Recent Development
Table 94. Merck Corporation Information
Table 95. Merck Description and Major Businesses
Table 96. Merck HIV Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Merck Product
Table 98. Merck Recent Development
Table 99. Global HIV Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global HIV Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global HIV Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global HIV Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: HIV Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: HIV Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: HIV Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: HIV Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: HIV Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: HIV Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: HIV Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: HIV Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: HIV Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: HIV Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key HIV Drugs Players
Table 117. HIV Drugs Customers List
Table 118. HIV Drugs Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. HIV Drugs Product Picture
Figure 2. Global HIV Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Multi-Class Combination Products Product Picture
Figure 4. Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 5. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 6. Protease Inhibitors Product Picture
Figure 7. Fusion Inhibitors Product Picture
Figure 8. Entry Inhibitors - CCR5 Co-Receptor Antagonist Product Picture
Figure 9. HIV Integrase Strand Transfer Inhibitors Product Picture
Figure 10. Global HIV Drugs Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Others
Figure 15. HIV Drugs Report Years Considered
Figure 16. Global HIV Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global HIV Drugs Sales 2015-2026 (K MT)
Figure 18. Global HIV Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global HIV Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global HIV Drugs Sales Market Share by Region in 2019
Figure 21. Global HIV Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global HIV Drugs Revenue Market Share by Region in 2019
Figure 23. Global HIV Drugs Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by HIV Drugs Revenue in 2019
Figure 25. HIV Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global HIV Drugs Sales Market Share by Type (2015-2020)
Figure 27. Global HIV Drugs Sales Market Share by Type in 2019
Figure 28. Global HIV Drugs Revenue Market Share by Type (2015-2020)
Figure 29. Global HIV Drugs Revenue Market Share by Type in 2019
Figure 30. Global HIV Drugs Market Share by Price Range (2015-2020)
Figure 31. Global HIV Drugs Sales Market Share by Application (2015-2020)
Figure 32. Global HIV Drugs Sales Market Share by Application in 2019
Figure 33. Global HIV Drugs Revenue Market Share by Application (2015-2020)
Figure 34. Global HIV Drugs Revenue Market Share by Application in 2019
Figure 35. North America HIV Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 36. North America HIV Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America HIV Drugs Sales Market Share by Country in 2019
Figure 38. North America HIV Drugs Revenue Market Share by Country in 2019
Figure 39. U.S. HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 40. U.S. HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 42. Canada HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America HIV Drugs Market Share by Type in 2019
Figure 44. North America HIV Drugs Market Share by Application in 2019
Figure 45. Europe HIV Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe HIV Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe HIV Drugs Sales Market Share by Country in 2019
Figure 48. Europe HIV Drugs Revenue Market Share by Country in 2019
Figure 49. Germany HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. France HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe HIV Drugs Market Share by Type in 2019
Figure 60. Europe HIV Drugs Market Share by Application in 2019
Figure 61. Asia Pacific HIV Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 62. Asia Pacific HIV Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific HIV Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific HIV Drugs Revenue Market Share by Region in 2019
Figure 65. China HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. China HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. Japan HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. South Korea HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. India HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Australia HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Taiwan HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Indonesia HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Thailand HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Malaysia HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 84. Philippines HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 86. Vietnam HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific HIV Drugs Market Share by Type in 2019
Figure 88. Asia Pacific HIV Drugs Market Share by Application in 2019
Figure 89. Latin America HIV Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America HIV Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America HIV Drugs Sales Market Share by Country in 2019
Figure 92. Latin America HIV Drugs Revenue Market Share by Country in 2019
Figure 93. Mexico HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 98. Argentina HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America HIV Drugs Market Share by Type in 2019
Figure 100. Latin America HIV Drugs Market Share by Application in 2019
Figure 101. Middle East and Africa HIV Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 102. Middle East and Africa HIV Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa HIV Drugs Sales Market Share by Country in 2019
Figure 104. Middle East and Africa HIV Drugs Revenue Market Share by Country in 2019
Figure 105. Turkey HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. Turkey HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 108. Saudi Arabia HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E HIV Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 110. U.A.E HIV Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa HIV Drugs Market Share by Type in 2019
Figure 112. Middle East and Africa HIV Drugs Market Share by Application in 2019
Figure 113. North America HIV Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America HIV Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe HIV Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe HIV Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific HIV Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific HIV Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America HIV Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America HIV Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa HIV Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa HIV Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
抗レトロウイルス薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-Retroviral Drugs Market The global Anti-Retroviral Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-Retroviral Drugs Scope and Market Size Anti-Retroviral Drugs marke…- ヒト免疫不全ウイルス（HIV）-1治療薬の世界市場（～2026年） The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…
- HIV治療薬の世界市場（～2026年） The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease. HIV spreads through fluidic …
- TNF阻害剤の世界市場（～2026年） TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- シグナル伝達阻害剤の世界市場（～2026年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…